The estimated Net Worth of Vii Associates Lpblair Jame... is at least $65.5 millier dollars as of 26 May 2016. Vii Jame owns over 5,880 units of Obalon Therapeutics Inc stock worth over $28,609 and over the last 9 years Vii sold OBLN stock worth over $36,846.
Vii has made over 5 trades of the Obalon Therapeutics Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Vii sold 5,880 units of OBLN stock worth $27,636 on 26 May 2016.
The largest trade Vii's ever made was selling 5,880 units of Obalon Therapeutics Inc stock on 26 May 2016 worth over $27,636. On average, Vii trades about 1,270 units every 8 days since 2016. As of 26 May 2016 Vii still owns at least 10,328 units of Obalon Therapeutics Inc stock.
You can see the complete history of Vii Jame stock trades at the bottom of the page.
Over the last 8 years, insiders at Obalon Therapeutics Inc have traded over $0 worth of Obalon Therapeutics Inc stock and bought 3,260,355 units worth $6,939,913 . The most active insiders traders include Parters Vii L Pblair James ..., Partners X Lp Inter West Ma... et David Moatazedi. On average, Obalon Therapeutics Inc executives and independent directors trade stock every 54 days with the average trade being worth of $432,771. The most recent stock trade was executed by William J. Plovanic on 12 November 2019, trading 65,000 units of OBLN stock currently worth $107,900.
Obalon Therapeutics, Inc. is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.
Obalon Therapeutics Inc executives and other stock owners filed with the SEC include: